Zinc in PDB 5edh: Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7%
Enzymatic activity of Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7%
All present enzymatic activity of Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7%:
3.1.4.17;
3.1.4.35;
Protein crystallography data
The structure of Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7%, PDB code: 5edh
was solved by
C.Joseph,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.68 /
2.03
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.401,
135.401,
235.335,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
18.6 /
22.7
|
Other elements in 5edh:
The structure of Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7% also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7%
(pdb code 5edh). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7%, PDB code: 5edh:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5edh
Go back to
Zinc Binding Sites List in 5edh
Zinc binding site 1 out
of 4 in the Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7%
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:31.2
occ:1.00
|
O
|
A:HOH966
|
2.0
|
27.2
|
1.0
|
NE2
|
A:HIS529
|
2.1
|
28.5
|
1.0
|
NE2
|
A:HIS563
|
2.1
|
29.6
|
1.0
|
OD2
|
A:ASP564
|
2.2
|
30.4
|
1.0
|
OD1
|
A:ASP674
|
2.2
|
28.6
|
1.0
|
O
|
A:HOH962
|
2.5
|
41.7
|
1.0
|
CD2
|
A:HIS563
|
3.0
|
26.6
|
1.0
|
CE1
|
A:HIS529
|
3.1
|
26.4
|
1.0
|
CG
|
A:ASP564
|
3.1
|
29.1
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
26.6
|
1.0
|
CG
|
A:ASP674
|
3.2
|
27.6
|
1.0
|
CE1
|
A:HIS563
|
3.2
|
28.8
|
1.0
|
OD2
|
A:ASP674
|
3.4
|
30.9
|
1.0
|
OD1
|
A:ASP564
|
3.5
|
26.8
|
1.0
|
MG
|
A:MG802
|
3.7
|
27.6
|
1.0
|
CD2
|
A:HIS525
|
4.0
|
28.1
|
1.0
|
CG
|
A:HIS563
|
4.2
|
27.3
|
1.0
|
O
|
A:HOH999
|
4.2
|
23.9
|
1.0
|
ND1
|
A:HIS529
|
4.2
|
27.0
|
1.0
|
ND1
|
A:HIS563
|
4.2
|
29.1
|
1.0
|
CG
|
A:HIS529
|
4.3
|
28.3
|
1.0
|
CB
|
A:ASP564
|
4.3
|
27.3
|
1.0
|
NE2
|
A:HIS525
|
4.4
|
29.6
|
1.0
|
O
|
A:HOH970
|
4.5
|
35.7
|
1.0
|
CB
|
A:ASP674
|
4.5
|
27.4
|
1.0
|
O
|
A:HOH908
|
4.5
|
24.4
|
1.0
|
CG2
|
A:VAL533
|
4.7
|
24.3
|
1.0
|
CA
|
A:ASP674
|
4.8
|
25.6
|
1.0
|
O
|
A:ASP674
|
4.9
|
28.1
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5edh
Go back to
Zinc Binding Sites List in 5edh
Zinc binding site 2 out
of 4 in the Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7%
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:28.9
occ:1.00
|
OD1
|
B:ASP674
|
2.2
|
27.0
|
1.0
|
O
|
B:HOH975
|
2.2
|
24.3
|
1.0
|
NE2
|
B:HIS563
|
2.2
|
25.5
|
1.0
|
OD2
|
B:ASP564
|
2.2
|
25.2
|
1.0
|
NE2
|
B:HIS529
|
2.2
|
22.7
|
1.0
|
O
|
B:HOH915
|
2.9
|
50.9
|
1.0
|
CG
|
B:ASP674
|
3.0
|
28.2
|
1.0
|
CD2
|
B:HIS563
|
3.0
|
25.1
|
1.0
|
CD2
|
B:HIS529
|
3.1
|
26.5
|
1.0
|
CG
|
B:ASP564
|
3.2
|
25.1
|
1.0
|
CE1
|
B:HIS563
|
3.2
|
24.9
|
1.0
|
OD2
|
B:ASP674
|
3.2
|
29.5
|
1.0
|
CE1
|
B:HIS529
|
3.3
|
26.0
|
1.0
|
OD1
|
B:ASP564
|
3.6
|
25.4
|
1.0
|
MG
|
B:MG802
|
3.8
|
25.1
|
1.0
|
CD2
|
B:HIS525
|
3.9
|
24.1
|
1.0
|
O
|
B:HOH1004
|
4.1
|
23.1
|
1.0
|
CG
|
B:HIS563
|
4.2
|
25.5
|
1.0
|
ND1
|
B:HIS563
|
4.3
|
25.4
|
1.0
|
CG
|
B:HIS529
|
4.3
|
25.3
|
1.0
|
NE2
|
B:HIS525
|
4.3
|
26.8
|
1.0
|
ND1
|
B:HIS529
|
4.4
|
24.0
|
1.0
|
CB
|
B:ASP564
|
4.4
|
23.2
|
1.0
|
CB
|
B:ASP674
|
4.4
|
27.4
|
1.0
|
O
|
B:HOH972
|
4.5
|
37.0
|
1.0
|
O
|
B:HOH951
|
4.5
|
24.9
|
1.0
|
CG2
|
B:VAL533
|
4.7
|
18.8
|
1.0
|
O
|
B:HOH1042
|
4.7
|
47.2
|
1.0
|
CA
|
B:ASP674
|
4.9
|
25.3
|
1.0
|
O
|
B:ASP674
|
5.0
|
24.3
|
1.0
|
O
|
B:HOH927
|
5.0
|
20.3
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5edh
Go back to
Zinc Binding Sites List in 5edh
Zinc binding site 3 out
of 4 in the Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7%
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:31.0
occ:1.00
|
O
|
C:HOH954
|
2.1
|
24.6
|
1.0
|
NE2
|
C:HIS529
|
2.2
|
27.4
|
1.0
|
NE2
|
C:HIS563
|
2.2
|
25.1
|
1.0
|
OD2
|
C:ASP564
|
2.2
|
24.8
|
1.0
|
OD1
|
C:ASP674
|
2.2
|
24.9
|
1.0
|
O
|
C:HOH941
|
2.5
|
49.2
|
1.0
|
CD2
|
C:HIS563
|
3.0
|
24.2
|
1.0
|
CD2
|
C:HIS529
|
3.1
|
28.9
|
1.0
|
CG
|
C:ASP674
|
3.1
|
27.5
|
1.0
|
CG
|
C:ASP564
|
3.1
|
24.8
|
1.0
|
CE1
|
C:HIS529
|
3.2
|
29.1
|
1.0
|
CE1
|
C:HIS563
|
3.3
|
24.8
|
1.0
|
OD2
|
C:ASP674
|
3.3
|
31.7
|
1.0
|
OD1
|
C:ASP564
|
3.6
|
25.8
|
1.0
|
MG
|
C:MG802
|
3.8
|
26.1
|
1.0
|
CD2
|
C:HIS525
|
3.9
|
28.4
|
1.0
|
O
|
C:HOH1001
|
4.2
|
23.4
|
1.0
|
CG
|
C:HIS563
|
4.2
|
25.0
|
1.0
|
CG
|
C:HIS529
|
4.2
|
28.5
|
1.0
|
ND1
|
C:HIS529
|
4.3
|
26.8
|
1.0
|
ND1
|
C:HIS563
|
4.3
|
24.6
|
1.0
|
NE2
|
C:HIS525
|
4.3
|
29.4
|
1.0
|
CB
|
C:ASP564
|
4.3
|
23.9
|
1.0
|
CB
|
C:ASP674
|
4.5
|
26.1
|
1.0
|
O
|
C:HOH943
|
4.5
|
25.1
|
1.0
|
O
|
C:HOH986
|
4.5
|
38.2
|
1.0
|
O
|
C:HOH1033
|
4.6
|
48.9
|
1.0
|
CG2
|
C:VAL533
|
4.7
|
22.9
|
1.0
|
CA
|
C:ASP674
|
4.9
|
27.9
|
1.0
|
O
|
C:ASP674
|
5.0
|
29.1
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5edh
Go back to
Zinc Binding Sites List in 5edh
Zinc binding site 4 out
of 4 in the Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7%
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Human PDE10A, 8-Ethyl-5-Methyl-2-[2-(2-Methyl-5-Pyrrolidin-1-Yl-1,2,4- Triazol-3-Yl)Ethyl]-[1,2,4]Triazolo[1,5-C]Pyrimidine, 2.03A, H3, Rfree=22.7% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:39.8
occ:1.00
|
O
|
D:HOH923
|
1.9
|
30.2
|
1.0
|
NE2
|
D:HIS563
|
2.2
|
33.8
|
1.0
|
NE2
|
D:HIS529
|
2.3
|
40.3
|
1.0
|
OD2
|
D:ASP564
|
2.3
|
36.0
|
1.0
|
OD1
|
D:ASP674
|
2.3
|
33.8
|
1.0
|
O
|
D:HOH914
|
2.6
|
53.8
|
1.0
|
CD2
|
D:HIS563
|
2.9
|
33.6
|
1.0
|
CG
|
D:ASP674
|
3.1
|
32.9
|
1.0
|
CG
|
D:ASP564
|
3.2
|
34.2
|
1.0
|
CD2
|
D:HIS529
|
3.2
|
41.7
|
1.0
|
CE1
|
D:HIS529
|
3.2
|
38.7
|
1.0
|
OD2
|
D:ASP674
|
3.3
|
35.8
|
1.0
|
CE1
|
D:HIS563
|
3.4
|
36.3
|
1.0
|
OD1
|
D:ASP564
|
3.6
|
34.0
|
1.0
|
MG
|
D:MG802
|
3.8
|
40.4
|
1.0
|
CD2
|
D:HIS525
|
4.0
|
37.3
|
1.0
|
O
|
D:HOH935
|
4.1
|
36.4
|
1.0
|
CG
|
D:HIS563
|
4.2
|
32.8
|
1.0
|
ND1
|
D:HIS529
|
4.4
|
39.7
|
1.0
|
ND1
|
D:HIS563
|
4.4
|
35.1
|
1.0
|
CB
|
D:ASP564
|
4.4
|
34.7
|
1.0
|
CG
|
D:HIS529
|
4.4
|
39.1
|
1.0
|
NE2
|
D:HIS525
|
4.4
|
43.1
|
1.0
|
O
|
D:HOH954
|
4.5
|
47.0
|
1.0
|
CB
|
D:ASP674
|
4.5
|
32.5
|
1.0
|
O
|
D:HOH903
|
4.5
|
34.1
|
1.0
|
CG2
|
D:VAL533
|
4.7
|
34.4
|
1.0
|
O
|
D:ASP674
|
4.9
|
36.4
|
1.0
|
CA
|
D:ASP674
|
4.9
|
34.0
|
1.0
|
|
Reference:
B.Kuhn,
W.Guba,
J.Hert,
D.Banner,
C.Bissantz,
S.Ceccarelli,
W.Haap,
M.Korner,
A.Kuglstatter,
C.Lerner,
P.Mattei,
W.Neidhart,
E.Pinard,
M.G.Rudolph,
T.Schulz-Gasch,
T.Woltering,
M.Stahl.
A Real-World Perspective on Molecular Design. J.Med.Chem. V. 59 4087 2016.
ISSN: ISSN 0022-2623
PubMed: 26878596
DOI: 10.1021/ACS.JMEDCHEM.5B01875
Page generated: Sun Oct 27 15:11:09 2024
|